I truly hope Nuro can hold some of the gains, in the past good news was met by huge selling pressure and the PPS drops right back to the $2.00 range.
Nuro recently received approval to market their DPN Check test kit in Japan.
Nuro has applied for regulatory approval to market their DPN Check product and is awaiting regulatory approval in China which has the potential to become an explosive market considering the huge population.
Nuro recently received FDA approval for their Sensus Pain Management device for use during Sleep for patients with Diabetic Neuropathy.
Now Today they received FDA approval for their Sensus Pain Management device for over the counter use, which means you will be able to buy the product at your local CVS pharmacy or Rite Aid.
There is a strong demand for Alternative Pain Management products considering the only alternate pain management product is Opiates, like Vicodin and Oxy Codone. We all know that the opiates lead to dependency and addiction.
I think the future looks very bright for Neurometrix, especially with their pending approval for DPN-Check in China right around the corner.